Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell Viability Assays Market, by Product
1.4.2 North America Cell Viability Assays Market, by End User
1.4.3 North America Cell Viability Assays Market, by Application
1.4.4 North America Cell Viability Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Cell Viability Assays Market by Product
4.1 North America Consumables Market by Country
4.2 North America Cell Viability Assays Market by Consumables Type
4.2.1 North America Reagents & Assay Kits Market by Country
4.2.2 North America Cell Viability Assays Market by Reagents & Assay Kits Type
4.2.2.1 North America Luminometric Assays Market by Country
4.2.2.2 North America Dye Exclusion Assays Market by Country
4.2.2.3 North America Colorimetric Assays Market by Country
4.2.2.4 North America Fluorometric Assays Market by Country
4.2.3 North America Microplates Market by Country
4.3 North America Instruments Market by Country
4.4 North America Cell Viability Assays Market by Instruments Type
4.4.1 North America Spectrophotometer Market by Country
4.4.2 North America Microscopy Market by Country
4.4.3 North America Cell Imaging & Analysis System Market by Country
4.4.4 North America Flow Cytometry Market by Country
4.4.5 North America Others Market by Country
Chapter 5. North America Cell Viability Assays Market by End-user
5.1 North America Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 North America CROs & CMOs Market by Country
5.3 North America Academic & Research Institutes Market by Country
5.4 North America Diagnostic Labs Market by Country
Chapter 6. North America Cell Viability Assays Market by Application
6.1 North America Stem Cell Research Market by Country
6.2 North America Drug Discovery & Development Market by Country
6.3 North America Diagnostics Market by Country
Chapter 7. North America Cell Viability Assays Market by Country
7.1 US Cell Viability Assays Market
7.1.1 US Cell Viability Assays Market by Product
7.1.1.1 US Cell Viability Assays Market by Consumables Type
7.1.1.1.1 US Cell Viability Assays Market by Reagents & Assay Kits Type
7.1.1.2 US Cell Viability Assays Market by Instruments Type
7.1.2 US Cell Viability Assays Market by End-user
7.1.3 US Cell Viability Assays Market by Application
7.2 Canada Cell Viability Assays Market
7.2.1 Canada Cell Viability Assays Market by Product
7.2.1.1 Canada Cell Viability Assays Market by Consumables Type
7.2.1.1.1 Canada Cell Viability Assays Market by Reagents & Assay Kits Type
7.2.1.2 Canada Cell Viability Assays Market by Instruments Type
7.2.2 Canada Cell Viability Assays Market by End-user
7.2.3 Canada Cell Viability Assays Market by Application
7.3 Mexico Cell Viability Assays Market
7.3.1 Mexico Cell Viability Assays Market by Product
7.3.1.1 Mexico Cell Viability Assays Market by Consumables Type
7.3.1.1.1 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type
7.3.1.2 Mexico Cell Viability Assays Market by Instruments Type
7.3.2 Mexico Cell Viability Assays Market by End-user
7.3.3 Mexico Cell Viability Assays Market by Application
7.4 Rest of North America Cell Viability Assays Market
7.4.1 Rest of North America Cell Viability Assays Market by Product
7.4.1.1 Rest of North America Cell Viability Assays Market by Consumables Type
7.4.1.1.1 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type
7.4.1.2 Rest of North America Cell Viability Assays Market by Instruments Type
7.4.2 Rest of North America Cell Viability Assays Market by End-user
7.4.3 Rest of North America Cell Viability Assays Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Abcam plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. Biotium, Inc.
8.10.1 Company Overview
Unique Offerings 
